MMP2 and neoplasm: In the TNBC microenvironment, the “two-in-one” ILips facilitated the MMP2-responsive release of aCD47 to efficiently polarize the M2 macrophages toward the M1 phenotype to enhance the phagocytosis of tumor cells and activate the systemic T-cell immune response.